Interim agreement under FSS schedule 65 I B drugs, pharmaceuticals, & hematology related products
Ended Federal Supply Schedule Awarded Last action
- Contract number
- 36F79726D031E
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI ENNFDLWFC6L1
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 5
Award facts
- Last date to order 100% complete
- IDV ceiling
- $25,000.00
- Award type
- Multiple award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
GSA issued a Federal Supply Schedule contract to Takeda Pharmaceuticals America, Inc. under FSS Schedule 65 IB (Drugs, Pharmaceuticals, & Hematology Related Products) on February 15, 2026, with an ultimate completion date of August 14, 2026 and a contract ceiling of $25,000.
This is a multiple-award schedule vehicle administered by Veterans Integrated Service Network 12 on behalf of the Department of Veterans Affairs. Takeda is approved to supply drugs, pharmaceuticals, and hematology-related products through the schedule's price-list mechanism, allowing VA facilities and other federal agencies to place orders without conducting separate competitions. The company's federal healthcare portfolio centers on oncology medications, including ICLUSIG (ponatinib) in multiple dosage strengths (10 milligram, 15 milligram, 30 milligram, and 45 milligram tablets), a targeted cancer therapy for chronic myeloid leukemia and acute lymphoblastic leukemia treatment. Delivery orders under related Takeda schedule contracts have ranged from approximately $11,000 to $173,000 and have been issued by multiple Veterans Integrated Service Networks (VISN 5, VISN 6, VISN 9, VISN 10, VISN 12, VISN 20, VISN 21, VISN 22, and VISN 23), with orders also placed by the Federal Correctional Complex Florence for chemotherapy medications. Performance occurs at Earth City, Missouri and Cambridge, Massachusetts. Takeda Pharmaceuticals America is a large, foreign-owned manufacturer with no small business set-aside designation.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Takhzyro 150 MG | Veterans Integrated Service Network 5 (VHA) | $0 | |
| Takhzyro 150 MG | Veterans Integrated Service Network 5 (VHA) | $38,098 | |
| Takhzyro 150 MG | Veterans Integrated Service Network 5 (VHA) | $38,098 | |
| Gattex 5 MG | Veterans Integrated Service Network 5 (VHA) | $34,605 | |
| Takhzyro 150 MG | Veterans Integrated Service Network 5 (VHA) | $38,098 |
IDV awards
| IDV | Agency | Ceiling | Awarded |
|---|---|---|---|
| 36E79726A0012 | National Acquisition Center (VA) | $851,917,905 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36F79726D031E?
36F79726D031E was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on February 15, 2026.
How much is contract 36F79726D031E worth?
36F79726D031E's own ceiling is $25,000.
How many orders have been placed under contract 36F79726D031E?
5 orders have been placed under 36F79726D031E, the latest on August 27, 2026.
Who can order from contract 36F79726D031E?
36F79726D031E is a multiple award federal supply schedule. All agencies can place orders on it.
Was contract 36F79726D031E competed?
The extent of competition for 36F79726D031E was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV